Joseph J. Larosa
Known title: EVP General Counsel and SecretCIK: 0001238303
Associated companies
Transaction History
| REGN | ▲ Buy | Option Exercise | 12,282 | $4.7M | 8/19/2026 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 9,019 | $7.5M | 8/19/2026 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 1,396 | $995K | 12/8/2025 | View on chart |
| REGN | ▲ Buy | Grant | 2,476 | $0 | 12/5/2025 | View on chart |
| REGN | ▲ Buy | Option Exercise | 14,450 | $8.0M | 11/20/2025 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 12,686 | $9.3M | 11/20/2025 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 702 | $513K | 12/16/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 492 | $387K | 12/9/2024 | View on chart |
| REGN | ▲ Buy | Grant | 2,332 | $0 | 12/6/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,866 | $2.0M | 7/11/2024 | View on chart |
| REGN | ▲ Buy | Option Exercise | 14,450 | $8.0M | 6/24/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 11,084 | $11.8M | 6/24/2024 | View on chart |
| REGN | ▼ Sell | Gift | 1,608 | $0 | 6/10/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,865 | $1.9M | 5/21/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,000 | $990K | 2/26/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,000 | $968K | 2/22/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,000 | $950K | 2/7/2024 | View on chart |
| REGN | ▲ Buy | Option Exercise | 34,000 | $13.6M | 1/3/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 24,493 | $22.3M | 1/3/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 669 | $565K | 12/11/2023 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 852 | $719K | 12/8/2023 | View on chart |
| REGN | ▲ Buy | Grant | 2,133 | $0 | 12/8/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 10,000 | $2.7M | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 6,742 | $5.4M | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Gift | 1,006 | $0 | 3/10/2023 | View on chart |
| REGN | ▲ Buy | Grant | 2,752 | $0 | 12/16/2022 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 492 | $371K | 12/9/2022 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 20,730 | $15.2M | 9/9/2022 | View on chart |
| REGN | ▲ Buy | Option Exercise | 30,000 | $8.1M | 9/9/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 5,114 | $3.7M | 4/7/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 369 | $253K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 799 | $550K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 250 | $173K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 641 | $443K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 557 | $382K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 497 | $342K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 218 | $150K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 195 | $135K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 567 | $393K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 259 | $180K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 305 | $212K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 254 | $177K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 64 | $45K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 124 | $87K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Open Market | 15 | $11K | 4/1/2022 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 697 | $463K | 12/11/2021 | View on chart |
| REGN | ▲ Buy | Option Exercise | 30,000 | $5.4M | 12/9/2021 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 19,772 | $13.0M | 12/9/2021 | View on chart |
| REGN | ▲ Buy | Grant | 3,338 | $0 | 12/8/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 1 | $666 | 8/23/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 3,383 | $2.2M | 8/23/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 41 | $27K | 8/23/2021 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 6,575 | $4.4M | 8/20/2021 | View on chart |
| REGN | ▲ Buy | Option Exercise | 10,000 | $1.8M | 8/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock
Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock. Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.